Endotoxin contamination alters macrophage-cancer cell interaction and therapeutic efficacy in pre-clinical 3D in vitro models

被引:7
|
作者
Heinrich, Marcel Alexander [1 ]
Heinrich, Lena [1 ]
Ankone, Marc J. K. [1 ]
Vergauwen, Bjorn [2 ]
Prakash, Jai [1 ]
机构
[1] Univ Twente, Tech Med Ctr, Dept Adv Organ Bioengn & Therapeut, Engn Therapeut Sect, NL-7500 AE Enschede, Netherlands
[2] Rousselot bvba, Expertise Ctr, B-9000 Ghent, Belgium
来源
BIOMATERIALS ADVANCES | 2023年 / 144卷
关键词
Lipopolysaccharide; 3D bioprinting; Gelatin methacryloyl; Tumor -associated macrophages; Immunotherapy; TUMOR-ASSOCIATED MACROPHAGES; LIPOPOLYSACCHARIDE; GROWTH; BIOMATERIALS;
D O I
10.1016/j.bioadv.2022.213220
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
The rapid developments in biofabrication, in particular 3D bioprinting, in the recent years have facilitated the need for novel biomaterials that aim to replicate the target tissue in great detail. The presence of endotoxins in these biomaterials is often an overlooked problem. In pre-clinical 3D in vitro models, endotoxins can have significant influence on cell behavior and credibility of the model. In this study we demonstrate the effects of high levels of endotoxins in commercially-available gelatin on the macrophage-cancer cell crosstalk in a 3D bioprinted co-culture model. First, it is demonstrated that, while presenting the same mechanical and structural stimuli, high levels of endotoxin can have significant influence on the metabolic activity of macrophages and cancer cells. Furthermore, this study shows that high endotoxin contamination causes a strong inflammatory reaction in macrophages and significantly inhibits the effects of a paracrine macrophage-cancer cell co-culture. At last, it is demonstrated that the differences in endotoxin levels can drastically alter the efficacy of novel macrophage modulating immunotherapies, AS1517499 and 3-methyladenine. Altogether, this study shows that endotoxin contamination in biomaterials can significantly alter intra- and intercellular communication and thereby drug efficacy, which might lead to misinterpretation of the potency and safety of the tested compounds.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] 3D in vitro co-culture disc for spatiotemporal image analysis of cancer-stromal cell interaction
    Takahashi, Haruko
    Kikuchi, Yutaka
    BIOMATERIALS SCIENCE, 2021, 9 (12) : 4448 - 4458
  • [42] 3D bioprinted microfluidic based osteosarcoma-on-a chip model as a physiomimetic pre-clinical drug testing platform for anti-cancer drugs
    Jaiswal, Chitra
    Dey, Souradeep
    Prasad, Jayant
    Gupta, Raghvendra
    Agarwala, Manoj
    Mandal, Biman B.
    BIOMATERIALS, 2025, 320
  • [43] A PD-L1 x CD3 bispecific antibody enhances the anti-tumor efficacy of regorafenib in pre-clinical colon cancer models
    Okpalanwaka, Izuchukwu F.
    Daugherity, Elizabeth A.
    McCormick, Amanda L.
    Anderson, Trevor S.
    Smith, Savanna L.
    Lawrence, Caryn
    Lowe, Devin B.
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [44] Replacement, Reduction, and Refinement of Animal Experiments in Anticancer Drug Development: The Contribution of 3D In Vitro Cancer Models in the Drug Efficacy Assessment
    Tosca, Elena M.
    Ronchi, Davide
    Facciolo, Daniele
    Magni, Paolo
    BIOMEDICINES, 2023, 11 (04)
  • [45] Mitoxantrone-loaded lipid nanoparticles for breast cancer therapy - Quality-by-design approach and efficacy assessment in 2D and 3D in vitro cancer models
    Granja, Andreia
    Lima-Sousa, Rita
    Alves, Catia G.
    de Melo-Diogo, Duarte
    Pinheiro, Marina
    Sousa, Celia T.
    Correia, Ilidio J.
    Reis, Salette
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2021, 607
  • [46] Development of 3D-iNET ORION: a novel, pre-clinical, three-dimensional in vitro cell model for modeling human metastatic neuroendocrine tumor of the pancreas
    Strnadel, Jan
    Valasek, Mark A.
    Lin, Grace Y.
    Lin, Huahui
    Tipps, Ann M. Ponsford
    Woo, Sang Myung
    Fujimura, Ken
    Wang, Huawei
    Choi, Sunkyu
    Bui, Jack
    Hermosillo, Christopher
    Jepsen, Kristen
    Navarro, Michael R.
    Kelber, Jonathan A.
    Klemke, Richard L.
    Bouvet, Michael
    HUMAN CELL, 2024, 37 (05) : 1593 - 1601
  • [48] Complex, patient-derived, multi-cell type, 3D models of breast cancer for personalized prediction of therapeutic response
    Guo, Qi
    Millard, Melissa
    Wilhelm, Christine
    Elrod, Ashley
    Erdman, Nick
    Dobrolecki, Lacey E.
    McKinley, Brian
    Rippon, Mary
    Cornett, Wendy
    Rinkliff, John
    Scopteuolo, Amanda
    Gray, Linda
    Epling, James
    Garner, Barbara
    Hanna, Jeff
    McGill, Eric
    Williams, C. David
    Schammel, David
    Kaplan, David L.
    Corless, Christopher
    Edenfield, Jeff
    Lewis, Michael T.
    Crosswell, Howland E.
    DesRochers, Teresa M.
    CANCER RESEARCH, 2018, 78 (13)
  • [49] Improving therapeutic strategies for Head and Neck Cancer: Insights from 3D hypoxic cell culture models in treatment response evaluation
    Ostapowicz, Julia
    Ostrowska, Kamila
    Golusinski, Wojciech
    Kulcenty, Katarzyna
    Suchorska, Wiktoria M.
    ADVANCES IN MEDICAL SCIENCES, 2024, 69 (02): : 368 - 376
  • [50] Beyond 2D cell cultures: how 3D models are changing the in vitro study of ovarian cancer and how to make the most of them
    Cortesi, Marilisa
    Warton, Kristina
    Ford, Caroline E.
    PEERJ, 2024, 12